Certolizumab Pegol for Treatment of Plaque Psoriasis: Pooled Three-Year Efficacy Outcomes from Two Phase 3 Trials (CIMPASI-1 and CIMPASI-2). J of Skin. 2020;4(5):s44. doi:10.25251/skin.4.supp.44